7Baggers
 published on: 2025-11-16 21:22:14  newser.com Mon, 17 Nov 2025 03:22:14 GMT
 Published on: 2025-11-16 02:19:27  newser.com Sun, 16 Nov 2025 08:19:27 GMT
 Craig-Hallum Maintains Atossa Therapeutics(ATOS.US) With Buy Rating  富途牛牛 Sat, 15 Nov 2025 10:33:58 GMT
 published on: 2025-11-15 00:19:35  newser.com Sat, 15 Nov 2025 06:19:35 GMT
 Published on: 2025-11-14 16:52:34  newser.com Fri, 14 Nov 2025 22:52:34 GMT
 published on: 2025-11-14 15:41:16  newser.com Fri, 14 Nov 2025 21:41:16 GMT
 Atossa Therapeutics Reports Increased Q3 Losses Amid R&D Focus  TipRanks Thu, 13 Nov 2025 04:27:38 GMT
 Published on: 2025-11-12 16:40:16  newser.com Wed, 12 Nov 2025 22:40:16 GMT
 published on: 2025-11-12 08:55:26  newser.com Wed, 12 Nov 2025 14:55:26 GMT
 Atossa Therapeutics Q3 net loss widens as operating costs rise  MarketScreener Wed, 12 Nov 2025 13:25:49 GMT
 Atossa Therapeutics reports Q3 EPS (7c), consensus (7c)  TipRanks Wed, 12 Nov 2025 13:24:28 GMT
 published on: 2025-11-12 05:41:48  newser.com Wed, 12 Nov 2025 11:41:48 GMT
 published on: 2025-11-12 04:38:37  newser.com Wed, 12 Nov 2025 10:38:37 GMT
 published on: 2025-11-11 23:40:20  newser.com Wed, 12 Nov 2025 05:40:20 GMT
 atossa therapeutics: a watershed moment for investors  AD HOC NEWS Tue, 11 Nov 2025 09:15:04 GMT
 published on: 2025-11-06 03:50:54  Fundação Cultural do Pará Thu, 06 Nov 2025 06:50:54 GMT
 atossa genetics (atos) projected to post earnings on tuesday  MarketBeat Wed, 05 Nov 2025 16:04:17 GMT
 published on: 2025-11-03 03:32:49  newser.com Mon, 03 Nov 2025 09:32:49 GMT

Atossa Therapeutics, Inc
(NASDAQ:ATOS) 

ATOS stock logo

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cance...

Founded: 2008
Full Time Employees: 4
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends